Luxiq Foam Topical Foam 0.12pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Luxiq Foam: Topical foam (0.12%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Luxiq 0.12% Topical Foam
Drug Image file default-drug-image.png
Luxiq 0.12% Topical Foam
Drug Image file default-drug-image.png
Luxiq 0.12% Topical Foam
Drug Image file default-drug-image.png
Luxiq 0.12% Topical Foam

What is this Medicine?

BETAMETHASONE (bay ta METH a sone) is a corticosteroid. It is used to treat scaling, redness, and itching due to scalp problems such as scalp psoriasis.

CVS Pharmacy Patient Statistics for Luxiq Foam: Topical foam(0.12%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Luxiq 0.12% Topical Foam

NDC: 400760021
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Contact Dermatitis, Keloids, Mycosis Fungoides, Alopecia, Rhus Dermatitis, Necrobiosis Lipoidica Diabeticorum, Eczema, Pemphigus, Cutaneous T-cell Lymphoma (CTCL), Discoid Lupus Erythematosus, Granuloma Annulare, Dermatitis Herpetiformis, Seborrheic Dermatitis, Pruritus, Pityriasis Rosea, Psoriasis, Lichen Simplex, Stevens-Johnson Syndrome, Atopic Dermatitis, Lichen Planus, Exfoliative Dermatitis

Storage Information
Flammable, keep away from heat and flame
Do Not Store at Temperatures Above 120 degrees F (49 degrees C)
Protect from direct sunlight
Store at controlled room temperature (between 68 and 77 degrees F)
Luxiq 0.12% Topical Foam

Reported Side Effects for Luxiq 0.12% Topical Foam

Thinning Of Skin Incidence:
<33.0%*
Severity: SEVERE
Onset: DELAYED
Hypothalamic-pituitary-adrenal (HPA) Suppression Incidence:
<73.0%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Dry Skin Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Luxiq Foam

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5